Abstract
Manganese oxide supported on alumina and zirconia has been prepared by precipitation-impregnation method. The materials have been characterized by FT-IR, P-XRD, BET, TPD-NH3, TGA, SEM and TEM techniques for their textural properties. The catalytic activity of these materials has been explored in the synthesis of dihydropyrimidinones via.,Biginelli reaction. A rod like morphology is observed for zirconia containing 5% manganese oxide. These materials exhibited good catalytic activity in terms of isolated yield (>97%) and selectivity (100%) for the synthesis of dihydropyrimidinones. Acidity of the catalysts and the tetragonal phase of zirconia were found to play an important role in catalyzing this reaction. The catalyst with 5%Mn/ZrO2 exhibited distinctly different catalytic activity. The catalyst is reusable without losing its activity upto 5 cycles.
Keywords: Biginelli reaction, dihydropyrimidinones, manganese oxide on alumina/zirconia, role of acidity, solvent free synthesis.
Current Catalysis
Title:Catalytic Activity of Manganese Oxide Anchored on to Alumina and Zirconia for the Synthesis of Dihydropyrimidinones: Role of Acidity, Crystal Phase and Morphology
Volume: 3 Issue: 1
Author(s): Mahadevaiah Rekha, Hagalahalli N. Hareesh, Nagaraju Kathyayini and Narasimaiah Nagaraju
Affiliation:
Keywords: Biginelli reaction, dihydropyrimidinones, manganese oxide on alumina/zirconia, role of acidity, solvent free synthesis.
Abstract: Manganese oxide supported on alumina and zirconia has been prepared by precipitation-impregnation method. The materials have been characterized by FT-IR, P-XRD, BET, TPD-NH3, TGA, SEM and TEM techniques for their textural properties. The catalytic activity of these materials has been explored in the synthesis of dihydropyrimidinones via.,Biginelli reaction. A rod like morphology is observed for zirconia containing 5% manganese oxide. These materials exhibited good catalytic activity in terms of isolated yield (>97%) and selectivity (100%) for the synthesis of dihydropyrimidinones. Acidity of the catalysts and the tetragonal phase of zirconia were found to play an important role in catalyzing this reaction. The catalyst with 5%Mn/ZrO2 exhibited distinctly different catalytic activity. The catalyst is reusable without losing its activity upto 5 cycles.
Export Options
About this article
Cite this article as:
Rekha Mahadevaiah, Hareesh N. Hagalahalli, Kathyayini Nagaraju and Nagaraju Narasimaiah, Catalytic Activity of Manganese Oxide Anchored on to Alumina and Zirconia for the Synthesis of Dihydropyrimidinones: Role of Acidity, Crystal Phase and Morphology, Current Catalysis 2014; 3 (1) . https://dx.doi.org/10.2174/2211544703999140130115808
DOI https://dx.doi.org/10.2174/2211544703999140130115808 |
Print ISSN 2211-5447 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5455 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Systemic Lupus Erythematosus: Old and New Susceptibility Genes versus Clinical Manifestations
Current Genomics Impact of Aging on the Angiogenic Potential of the Myocardium: Implications for Angiogenic Therapies with Emphasis on Sirtuin Agonists
Recent Patents on Cardiovascular Drug Discovery Editorial [Hot Topic: Towards Tailored Treatment - New Organ-Specific Drug Strategies Interfering in Signal Transduction (Guest Editors: Jai Prakash and Martin H. de Borst)]
Current Signal Transduction Therapy Toll-Like Receptors: Cost or Benefit for Cancer?
Current Pharmaceutical Design Nanoparticulate Drug Delivery to Colorectal Cancer: Formulation Strategies and Surface Engineering
Current Pharmaceutical Design Antiviral Compounds Derived from Naturally Occurring Proteins
Current Medicinal Chemistry - Anti-Infective Agents P2Y Receptors: Focus on Structural, Pharmacological and Functional Aspects in the Brain
Current Medicinal Chemistry Selective Inhibitors of Hepatitis B Virus Replication
Current Medicinal Chemistry - Anti-Infective Agents Biosimilars Regulation in the United States and FDA Approved Biosimilars from 2015-2018
Applied Clinical Research, Clinical Trials and Regulatory Affairs Another Brick in the Wall: Innate Lymphoid Cells of the Intestine
Current Immunology Reviews (Discontinued) Higher Placental Anti-Inflammatory IL-10 Cytokine Expression in HIV-1 Infected Women Receiving Longer Zidovudine Prophylaxis Associated with Nevirapine
Current HIV Research Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future Perspectives
Current Drug Metabolism The Anticancer Activity of the N-Terminal CARD-Like Domain of Arginine Deiminase (ADI) from Pseudomonas aeruginosa
Letters in Drug Design & Discovery Validation and Development of N-glycan as Biomarker in Cancer Diagnosis
Current Pharmacogenomics and Personalized Medicine Antioxidant Effects of Natural Bioactive Compounds
Current Pharmaceutical Design Design of Multifunctional Compounds for Cardiovascular Disease: From Natural Scaffolds to “Classical” Multitarget Approach
Current Medicinal Chemistry Molecule of the Month
Current Topics in Medicinal Chemistry The Optimization of HL60-IL6 Assay and its Application in the Pyrogen Detection of Monoclonal Antibody
Current Pharmaceutical Analysis Amyloid Beta: The Alternate Hypothesis
Current Alzheimer Research Gene Expression Analysis for High Throughput Screening Applications
Combinatorial Chemistry & High Throughput Screening